Xlear today filed an Emergency Use Authorization (EUA) to the FDA to enable Xlear nasal spray be marketed, sold and used specifically to combat COVID-19.

I recently had the chance to speak with Nathan Jones, founder and CEO of Xlear, to learn more about how something as simple as a saline nasal solution can improve upper respiratory health.

Q&A: Xlear CEO explains Xlear Nasal Spray’s lasting role against COVID-19 Nathan Jones, CEO of Xlear, talked with Drug Store News about the challenges ahead.

Xlear Files Amended Answer to Government’s Lawsuit on COVID-19 Statements. Provides More Data Supporting Xlear’s Use as Additional Layer of Protection ...

Xlear’s Amended Answer provides two new studies that support the statements Xlear made about the use of its nasal spray as a potential additional layer of protection against COVID-19: ...

Xlear has been used by millions of people over the last twenty years for cleansing and moisturizing the nasal cavities without a single report of a significant adverse event. At the same time, ...

If everyone used Xlear, in addition to taking other steps recommended by public health officials, we believe we could drive SARS-CoV-2 infection rates down nationwide,' Jones added.

Xlear previously filed a pre-EUA seeking approval for use of the nasal spray as a medical device in combatting COVID-19. However, because the FDA determined that Xlear “works against the virus ...

Xlear previously filed a pre-EUA seeking approval for use of the nasal spray as a medical device in combatting COVID-19. However, because the FDA determined that Xlear “works against the virus,” the ...